αααααβααΎαCUP β’ FRA
add
Chugai Pharmaceutical Co Ltd
49.00β¬
29 ααααΆ, 11:15:39 AM ααααβααα +2 · EUR · FRA · ααα
ααααΈαααααΆααα·αααα½ααα»αααααΌα
αα·αααΈαα»α
48.93β¬
α
αααααααααααα
48.99β¬ - 49.00β¬
α
ααααααα½αααααΆαα
α»αααααα
26.87β¬ - 51.66β¬
ααΎαβαα»αβααΈααααΆα
13.46Β ααααΈααΆα JPY
ααα ααα½αααΌαααααα
62.00
α’αα»ααΆα P/E
-
αα·αααααβααΆαααΆα
-
ααΆααααααΌαα
αααα
TYO
αααα»αβααααααΆαβ
α α·ααααααααα»
αααΆαααΆαααααααΆααα
αααΌα
α
αααΌα
α
αααΌααα»ααα
| (JPY) | ααΈααΆ 2025info | ααΆαααααΆααααααΌαααΆαβααααΆα |
|---|---|---|
α
αααΌα | 288.46Β αααΈααΆα | 21.74% |
α
αααΆαααααα·ααααα·ααΆα | 63.99Β αααΈααΆα | -0.22% |
α
αααΌααα»ααα | 97.23Β αααΈααΆα | 30.69% |
ααααΆααα
αααααα»ααα | 33.71 | 7.36% |
βα
αααΌααα»αααβαααα»ααα½αααΆαα αα»α | β | β |
α
αααΌααα»ααααα»αααΆαααααΆαα αααα ααΆαααααα αα·αααΆαααΆααααααα | 137.05Β αααΈααΆα | 36.68% |
α’ααααΆαααααααααΆαααααα·αααααΆα | 28.41% | β |
αααααΈαααα»ααα
ααααααααα»α
ααΆαααα½ααα»αααααΌαααα»α
| (JPY) | ααΈααΆ 2025info | ααΆαααααΆααααααΌαααΆαβααααΆα |
|---|---|---|
ααΆα
αααααΆαα αα·αααΆααα·αα·αααααααααααααΈ | 944.55Β αααΈααΆα | 23.54% |
ααααααααα»α | 2.14Β ααααΈααΆα | 12.74% |
ααΆαααα½ααα»αααααΌαααα»α | 232.26Β αααΈααΆα | -9.17% |
ααΌαβααααα»α | 1.91Β ααααΈααΆα | β |
ααΆαα αα»αβαα·αβααΆααααΆαααα | 1.65Β αααΈααΆα | β |
ααααααααααΉαααααα
| 0.04 | β |
ααα
ααααααΎαααααα | 15.71% | β |
ααα
ααααααΎααΎααα»α | 17.94% | β |
ααα αΌαβααΆα
αβααααΆααβ
ααΆααααααααα½αβααΆα
αααααΆαααα»ααα
| (JPY) | ααΈααΆ 2025info | ααΆαααααΆααααααΌαααΆαβααααΆα |
|---|---|---|
α
αααΌααα»ααα | 97.23Β αααΈααΆα | 30.69% |
ααΆα
αααααΆααααΈααααα·ααααα·ααΆα | 66.68Β αααΈααΆα | -33.93% |
ααΆα
αααααΆααααΈααΆααα·αα·ααα | -86.89Β αααΈααΆα | -169.46% |
ααΆα
αααααΆααααΈα α·ααααβαααααΆα | -95.38Β αααΈααΆα | -42.63% |
ααΆααααααααα½αβααΆα
αααααΆαααα»ααα | -116.78Β αααΈααΆα | -2,887.85% |
ααα αΌαααΆα
αααααΆααααααα | 19.18Β αααΈααΆα | -75.37% |
α’αααΈ
Chugai Pharmaceutical Co., Ltd. is a drug manufacturer operating in Japan. It is a subsidiary controlled by Hoffmann-La Roche, which owns 62% of the company as of 30 June 2014. The company is headquartered in Tokyo. Osamu Nagayama is the current representative director and chairman. Tatsuro Kosaka is the current representative director, president and CEO. Wikipedia
CEO
ααΆααααααΎαα‘αΎα
10 ααΈααΆ 1925
αααααβαααααΆα
αα»ααααα·α
5,026
